— Know what they know.
Not Investment Advice
Also trades as: HUMAW (NASDAQ) · $vol 0M

HUMA NASDAQ

Humacyte, Inc.
1W: +2.0% 1M: +44.7% 3M: -9.7% YTD: +4.6% 1Y: -59.0% 3Y: -73.8% 5Y: -89.7%
$1.05
+0.03 (+2.94%)
After Hours: $1.04 (-0.01, -0.95%)
Weekly Expected Move ±19.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 62 · $176.4M mcap · 138M float · 5.04% daily turnover · Short 65% of daily vol

Balance Sheet Trends

Total Assets
$116M -15.6% ▼
5Y CAGR: +1.8%
Total Liabilities
$113M -40.6% ▼
5Y CAGR: +25.8%
Shareholders Equity
$3M +105.9% ▲
5Y CAGR: -46.5%
Cash & Investments
$50M +12.4% ▲
5Y CAGR: +4.8%
Total Debt
$65M +292.1% ▲
5Y CAGR: +17.6%
Net Debt
$14M +150.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$218M$150M$80M$45M$50M
Short-Term Investments$8M$2M$0$0$0
Cash & ST Investments$226M$152M$80M$45M$50M
Net Receivables$176K$31K$0$0$441K
Inventory$0$0$0$0$14M
Other Current Assets$0$2M$3M$3M$3M
Total Current Assets$229M$154M$83M$48M$68M
Property, Plant & Equip.$57M$50M$44M$39M$48M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$209K
Other Non-Current Assets$0$0$841K$51M$672K
Total Non-Current Assets$57M$50M$45M$90M$49M
Total Assets$287M$204M$128M$138M$116M
— Liabilities —
Accounts Payable$2M$2M$6M$4M$5M
Short-Term Debt$0$9M$0$0$2M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$4M$4M$5M$7M$11M
Total Current Liabilities$11M$20M$18M$20M$18M
Long-Term Debt$27M$20M$39M$0$35M
Other Non-Current Liab.$104M$29M$41M$157M$32M
Total Non-Current Liabilities$153M$68M$96M$171M$95M
Total Liabilities$164M$87M$115M$191M$113M
— Equity —
Common Stock$10K$10K$10K$13K$20K
Retained Earnings-$415M-$427M-$537M-$686M-$727M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$122M$117M$14M-$53M$3M
Total Liabilities & Equity$287M$204M$128M$138M$116M
— Key Metrics —
Total Debt$51M$50M$57M$17M$65M
Net Debt-$166M-$100M-$23M-$28M$14M
Total Investments$8M$2M$0$0$209K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms